Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-02-03

Clinical Trial Update: The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers [NA]

View source ↗

Summary

The clinical trial evaluating electronic auscultation with CALSA and FRI for asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: FLUIDDA nv | Conditions: Asthma | NA | Status: WITHDRAWN